Bioprocess Filtration Industry Set for 13.1% CAGR Growth, Reaching $15.6 Billion by 2030

“As demand for biologics, vaccines, and advanced therapies grows, bioprocess filtration is evolving fast. The report explores new technologies and market segments to help businesses uncover fresh opportunities and stay ahead.”

Boston, Feb. 04, 2026 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Bioprocess Filtration: Global Markets” is estimated to grow from $8.4 billion in 2025 to $15.6 billion by 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 through 2030.

This report offers a comprehensive analysis of the bioprocess filtration market, focusing on trends, growth drivers and challenges from 2024 through 2030. It highlights the increasing demand for biologics, gene therapies and cell-based treatments, which require stringent Good Manufacturing Practice (GMP)-compliant filtration solutions. The report categorizes the market into segments based on product type, filtering modality, process stage, application, end user, and region, with detailed insights into major countries for North America, Europe, Asia-Pacific, South America, the Middle East, and Africa.

Additionally, the report provides market size estimates, CAGR projections and competitive landscape evaluations, including regulatory influences and industry structure. It identifies key opportunities and restraints shaping the market and assesses the long-term impact of technological advances and evolving therapeutic needs. Market share analysis of leading companies further helps stakeholders understand the competitive dynamics and prepare for future developments in bioprocess filtration.

The factors driving the market include:

Biologics and Biosimilars Growth: Biologics are complex drugs made from living cells, including antibodies and vaccines. Biosimilars are close copies of biologics that offer similar treatment outcomes at lower cost. With increasing demand for targeted treatments in cancer and autoimmune diseases, more biologics are entering trials and reaching the market. This drives the need for scalable filtration systems to ensure product safety and purity.

CDMO/CMO Expansion: Pharmaceutical companies are increasingly outsourcing production to Contract Development and Manufacturing Organizations (CDMOs) and Contract Manufacturing Organizations (CMOs) that specialize in biomanufacturing. These organizations offer the expertise and infrastructure needed for efficient production, boosting demand for advanced filtration technologies that support flexible and high-volume operations.

Single-Use Technology Adoption: Single-use systems use disposable components such as filters and bags, reducing contamination risks and cleaning costs. Their growing use in small-batch and personalized medicine manufacturing is increasing the need for filtration solutions designed for single-use setups.

Rising Regulatory Approvals: With more biologics and cell and gene therapies receiving regulatory approvals from the Food and Drug Administration (FDA) and the European Medicines Agency (EMA), manufacturers must meet strict quality standards. This is driving demand for reliable filtration systems that ensure compliance and product integrity.

Request a sample copy of the Global Market for Bioprocess Filtration.

Report Synopsis

Report Metric	Details
Base year considered	2024
Forecast period considered	2025-2030
Base year market size	$7.6 billion
Market size forecast	$15.6 billion
Growth rate	CAGR of 13.1% from 2025 to 2030
Segments covered	Product Type, Filtering Modality, Process Stage, Application, End User and Region
Regions covered	North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America
Market Drivers	Growth of biologics and biosimilar pipeline. Expansion of CDMOs and CMOs specializing in biomanufacturing. Surge in single-use bioprocessing adoption. Increased regulatory approvals of biologics and cell and gene therapies.

Innovations:

• Cytiva (Danaher) invested $1.6 billion in 2025 to expand filtration and device capacity globally, including an 81% increase at its Ilfracombe, U.K. site, strengthening regional supply security.

• Merck Life Science committed €440 million in Cork, Ireland, to scale up its membrane and filtration manufacturing, reflecting rising demand for tangential flow filtration (TFF) and virus-removal technologies.

Emerging startups:

• Graver Technologies
• Membrane Solutions
• Suzhou Filterbio Membrane Co., Ltd.
• Axium Process Ltd.
• Foxx Life Sciences
• Qosina Corp.

AI Impact on Bioprocess Filtration Market

Artificial intelligence (AI) is accelerating real-time process monitoring and filtration parameter optimization, reducing cycle times and improving yield consistency in bioprocessing. Companies are increasing AI-driven investments in smart membranes, predictive analytics, and digital twins, signaling higher adoption and driving transformative changes in filtration system design and investment priorities. These advances are critical as biopharmaceutical manufacturers seek to meet stringent quality standards and time-sensitive production requirements.

The rapid adoption of AI in bioprocess filtration is driven by its ability to optimize production rates, maintain consistent product quality and comply with Process Analytical Technology (PAT) and Continued Process Verification (CPV) guidelines. By combining machine learning models with skid sensor data such as pressure, flow, temperature, conductivity, and UV alongside batch metadata and integrity test histories, manufacturers can achieve explicit quality and performance targets. AI transforms bioprocess filtration into a strategic operational tool, enabling flexible single-use manufacturing and ensuring quick, reliable biologic supply across multiple modalities.

For an in-depth analysis of AI’s impact on this sector, explore the complete AI Impact on the Bioprocess Filtration Market - BCC Pulse Report

The report addresses the following questions:

1. What are the projected market size and growth rate?

• The bioprocess filtration market estimated to reach $15.6 billion by the end of 2030, growing at a compound annual growth rate (CAGR) of 13.1% during the forecast period.

2. What factors are driving the growth of the market?

• Key drivers include:

• Growing biologics and biosimilar pipeline.
• Expansion of CDMOs and CMOs specializing in biomanufacturing.
• Surge in single-use bioprocessing (SUT) adoption.
• Rising regulatory approvals of biologics and cell and gene therapies.

3. What are the challenges and opportunities of the market?

• Key challenges include:

• Membrane material supply chain constraints.
• High cost of the filtration system.

• Key opportunities include:

• Smart sensors for filtration performance.
• Digital twins for predictive bioprocess control.
• Emerging markets driving decentralized biomanufacturing.

4. What market segments are covered in the report?

• The market is segmented by product type, filtration modality, process stage, application, end-user and region.

5. Which product type segment will be dominant through 2030?

• The consumables segment is expected to be dominant in the product type segment through 2030 because biologics manufacturers need cartridges and capsules, membranes and single-use assemblies for each production batch. The market dominance of consumables is expected to continue, driven by single-use technologies and the expansion of high-volume biologics pipelines.

6. Which region has the largest market share?

• The North America region has the largest market share. The market leadership of North America stems from its strong position of leading suppliers, including Danaher, Merck KGaA, Sartorius, and Repligen, as well as its well-developed biomanufacturing facilities and ongoing research into monoclonal antibodies, vaccines, and cell and gene therapies, which need strict filtration systems.

Market leaders include:

• AMAZON FILTERS LTD.
• ASAHI KASEI LIFE SCIENCE CORP.
• AVANTOR INC.
• COBETTER
• CYTIVA
• ENTEGRIS INC.
• MEISSNER FILTRATION PRODUCTS INC.
• MERCK KGAA
• PARKER-HANNIFIN CORP.
• PORVAIR FILTRATION GROUP
• REPLIGEN CORP.
• SAINT-GOBAIN LIFE SCIENCES
• SARTORIUS AG
• THERMO FISHER SCIENTIFIC INC.
• W. L. GORE & ASSOCIATES INC.

Purchase a copy of the report directly from BCC Research.

For further information or to make a purchase, contact info@bccresearch.com.    

About BCC Research

BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

BCC Research

Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, U.S.
Email: info@bccresearch.com
Phone: +1 781-489-7301

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.